This trial will help determine how effective a certain probiotic is in reducing urinary symptoms.
- Spinal Cord Injury
- Neurogenic Bladder
10 Primary · 0 Secondary · Reporting Duration: (SA2) 24-48 hours after intervention completion
Awards & Highlights
2 Treatment Groups
High Dosage Group
1 of 2
Low Dosage Group
1 of 2
182 Total Participants · 2 Treatment Groups
Primary Treatment: High Dosage Group · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How is High Dosage Group usually employed?
"The High Dosage Group is most often given to patients in order to alleviate vaginal symptoms. However, it can also be used to correct candidiasis of vagina, vaginal flora imbalance, and bacterial vaginosis." - Anonymous Online Contributor
What adverse effects have been seen in patients who have taken High Dosage Group?
"The High Dosage Group intervention has received a score of 3 for safety. This is because Phase 3 trials have shown some efficacy and there is supporting safety data from multiple rounds of trials." - Anonymous Online Contributor
Could you tell us about any other research conducted with High Dosage Group?
"High Dosage Group is being researched in 5 different clinical trials, with 1 of those trials in Phase 3. The majority of research is being conducted in Shenzhen, Guangdong; however, there are a total of 14 locations running clinical trials related to High Dosage Group." - Anonymous Online Contributor
Are participants being recruited for this research at this time?
"That is correct. The information available on clinicaltrials.gov suggests that this study is presently looking for 182 patients from 1 location. The data also shows that the study was first posted on 5/20/2020 and was last edited on 9/23/2022." - Anonymous Online Contributor